Evaluation of proton pump inhibitors and risks of gastric cancer

被引：2
作者：
Zeng, Ruijie [1 ,2 ]
Sha, Weihong [1 ]
Wang, Jinghua [3 ]
Zhuo, Zewei [1 ]
Wu, Huihuan [1 ]
Leung, Felix W. [4 ,5 ]
Chen, Hao [1 ]
机构：
[1] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China
[2] Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
[4] VA Greater Los Angeles Healthcare Syst, Sepulveda Ambulatory Care Ctr, Los Angeles, CA USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
GUT | 2022年 / 71卷 / 09期
基金：
中国国家自然科学基金;
关键词：
proton pump inhibition; gastric cancer; ASSOCIATION;
D O I：
10.1136/gutjnl-2021-326291
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1924 / 1926
页数：3
相关论文
共 50 条
  • [31] Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants
    Wan, Qian-Yi
    Wu, Xiao-Ting
    Li, Ni
    Du, Liang
    Zhou, Yong
    GUT, 2019, 68 (04)
  • [32] Platelet inhibitors and proton pump inhibitors: no more uncertainties?
    Jacobshagen, C.
    Hasenfuss, G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (15) : 799 - 801
  • [33] Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks
    Khan, Zuber
    Mehan, Sidharth
    Saifi, Mohd. Anas
    Das Gupta, Ghanshyam
    Narula, Acharan S.
    Kalfin, Reni
    CURRENT ALZHEIMER RESEARCH, 2023, 20 (11) : 739 - 757
  • [34] Updated Insights on Cardiac and Vascular Risks of Proton Pump Inhibitors: A Real-World Pharmacovigilance Study
    Zhai, Yinghong
    Ye, Xiaofei
    Hu, Fangyuan
    Xu, Jinfang
    Guo, Xiaojing
    Lin, Zhen
    Zhou, Xiang
    Guo, Zhijian
    Cao, Yang
    He, Jia
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [35] Nonsteroidal anti-inflammatory drugs prevent gastric cancer associated with the use of proton pump inhibitors after Helicobacter pylori eradication
    Arai, Junya
    Niikura, Ryota
    Hayakawa, Yoku
    Sato, Hiroki
    Kawahara, Takuya
    Honda, Tetsuro
    Hasatani, Kenkei
    Yoshida, Naohiro
    Nishida, Tsutomu
    Sumiyoshi, Tetsuya
    Kiyotoki, Shu
    Ikeya, Takashi
    Arai, Masahiro
    Suzuki, Nobumi
    Tsuji, Yosuke
    Yamada, Atsuo
    Koike, Kazuhiko
    JGH OPEN, 2021, 5 (07): : 770 - 777
  • [36] Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment
    Oura, Hirotaka
    Matsumura, Tomoaki
    Kawasaki, Yohei
    Okimoto, Kenichiro
    Ishikawa, Kentaro
    Kaneko, Tatsuya
    Tokunaga, Mamoru
    Oike, Tsubasa
    Imai, Yushi
    Yokoyama, Yuya
    Akizue, Naoki
    Maruoka, Daisuke
    Ohta, Yuki
    Saito, Keiko
    Nakagawa, Tomoo
    Arai, Makoto
    Kato, Jun
    Kato, Naoya
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (02) : 209 - 215
  • [37] Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
    Liu, Peipei
    McMenamin, Una C.
    Johnston, Brian T.
    Murchie, Peter
    Iversen, Lisa
    Lee, Amanda J.
    Vissers, Pauline A. J.
    Cardwell, Chris R.
    BRITISH JOURNAL OF CANCER, 2020, 123 (02) : 307 - 315
  • [38] Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study
    Shin, Ga-Yeong
    Park, Jae Myung
    Hong, Jinhyuk
    Cho, Yu Kyung
    Yim, Hyeon Woo
    Choi, Myung-Gyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (06) : 1211 - 1219
  • [39] Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal
    Poly, Tahmina Nasrin
    Lin, Ming-Chin
    Syed-Abdul, Shabbir
    Huang, Chih-Wei
    Yang, Hsuan-Chia
    Li, Yu-Chuan
    CANCERS, 2022, 14 (13)
  • [40] Are proton pump inhibitors really so dangerous?
    Savarino, Vincenzo
    Dulbecco, Pietro
    Savarino, Edoardo
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (08) : 851 - 859
12345